Antimicrobial Resistance Surveillance Market Report 2026

Antimicrobial Resistance Surveillance Market Overview

• Antimicrobial Resistance Surveillance market size has reached to $7.3 billion in 2025 • Expected to grow to $10.85 billion in 2030 at a compound annual growth rate (CAGR) of 8.2% • Growth Driver: Increasing Prevalence Of Infectious Diseases Fuels Antimicrobial Resistance Surveillance Market Growth • Market Trend: Technological Advancements In Diagnostic Tools For Enhanced Efficiency And Faster Patient Outcomes • North America was the largest region in 2025 and Asia-Pacific is the fastest growing region.

What Is Covered Under Antimicrobial Resistance Surveillance Market?

Antimicrobial resistance (AMR) surveillance refers to the systematic monitoring and tracking of the prevalence and spread of antimicrobial-resistant microorganisms. They are used for detecting emerging resistance patterns, guiding public health interventions, and informing treatment strategies to combat infections caused by resistant bacteria, viruses, and fungi. The main solutions in antimicrobial resistance surveillance are diagnostic kits, diagnostic systems, surveillance software, and services. Diagnostic kits refer to pre-packaged tools that help healthcare professionals quickly identify antimicrobial-resistant infections in patients. The various applications are clinical diagnostics, public health surveillance, and others and are used by end users such as hospitals and clinics, research and academic institutes, and others.

What Is The Antimicrobial Resistance Surveillance Market Growth Forecast?

The antimicrobial resistance surveillance market size is expected to see strong growth in the next few years. It will grow to $10.85 billion in 2030 at a compound annual growth rate (CAGR) of 8.2%. The growth in the forecast period can be attributed to global AMR monitoring initiatives, AI-driven predictive surveillance, cloud-based data sharing, genomic surveillance growth, policy-driven reporting mandates. Major trends in the forecast period include real-time resistance pattern monitoring, whole genome sequencing surveillance, AI-based resistance analytics, integrated public health databases, hospital-wide AMR tracking systems.

Global Antimicrobial Resistance Surveillance Market Segmentation

1) By Solution: Diagnostic Kits, Diagnostic Systems, Surveillance Software, Services 2) By Application: Clinical Diagnostics, Public Health Surveillance, Other Applications 3) By End User: Hospitals And Clinics, Research And Academic Institutes, Other End Users Subsegments: 1) By Diagnostic Kits: PCR-Based Kits, Immunoassay Kits, Lateral Flow Assay Kits 2) By Diagnostic Systems: Automated Susceptibility Testing Systems, Whole Genome Sequencing (WGS) Systems, Mass Spectrometry-Based Systems 3) By Surveillance Software: Cloud-Based Surveillance Platforms, AI-Powered Data Analytics Tools, Electronic Health Record (EHR)-Integrated Systems 4) By Services: Laboratory Testing Services, Data Management & Reporting Services, Consultation & Training Services

What Is The Driver Of The Antimicrobial Resistance Surveillance Market?

The increasing prevalence of infectious diseases is expected to propel the growth of the antimicrobial resistance surveillance market going forward. Infectious diseases are illnesses caused by harmful microorganisms such as bacteria, viruses, fungi, or parasites that can spread directly or indirectly from one individual to another. The rising prevalence of infectious diseases is attributed to factors such as climate change, urbanization, and global travel, which enhance pathogen spread and human exposure to new microbes. Antimicrobial resistance surveillance helps track the spread of resistant pathogens, guiding effective treatment strategies and informing public health policies to combat infectious diseases. For instance, in February 2024, according to a report published by the UK Health Security Agency, a UK-based government agency, tuberculosis (TB) cases in England increased by 10.7% in 2023, with 4,850 cases reported compared to 4,380 in 2022. Therefore, the increasing prevalence of infectious diseases is driving the growth of the antimicrobial resistance surveillance industry.

Key Players In The Global Antimicrobial Resistance Surveillance Market

Major companies operating in the antimicrobial resistance surveillance market are Roche Diagnostics, Thermo Fisher Scientific Inc., Abbott Laboratories, Danaher Corporation, Becton Dickinson and Company, bioMérieux SA, Bio‑Rad Laboratories Inc., Bruker Corporation, QIAGEN NV, Cepheid Inc., Accelerate Diagnostics Inc., Liofilchem S.r.l., Luminex Corporation, Sysmex Corporation, Werfen, OpGen Inc., Illumina Inc., Oxford Nanopore Technologies plc, Himedia Laboratories Pvt. Ltd., Alifax S.r.l.

Global Antimicrobial Resistance Surveillance Market Trends and Insights

Major companies operating in the market are focusing on innovative technologies, such as innovative diagnostic tools, to streamline processes, enhance efficiency, improve accuracy, reduce costs, and deliver better outcomes for patients and end-users. A diagnostic tool refers to any device, instrument, software, or methodology used to identify, detect, or assess the presence of a condition, disease, malfunction, or issue. For instance, in June 2023, Sysmex Astrego AB, a Sweden-based manufacturer and supplier of services for diagnostic products, announced the launch of the PA-100 AST Point-of-Care Testing System. This system enables rapid and accurate detection of antimicrobial resistance at the point of care, offering a significant reduction in time compared to traditional laboratory methods, which can take up to several days. By providing results in just 30 minutes, it allows clinicians to make timely and informed decisions about the appropriate treatment for infections, reducing the reliance on broad-spectrum antibiotics and helping to combat the spread of antimicrobial resistance.

What Are Latest Mergers And Acquisitions In The Antimicrobial Resistance Surveillance Market?

In January 2024, BioMérieux S.A., a France-based biotechnology company, acquired LUMED for an undisclosed amount. With this acquisition, BioMérieux aims to enhance its capabilities in fighting antimicrobial resistance and strengthen its portfolio, particularly in offering digital tools to improve antibiotic stewardship. LUMED Inc. is an Italy-based company focused on healthcare and medical data analysis, specializing in Antimicrobial Resistance (AMR) Surveillance.

Regional Outlook

North America was the largest region in the antimicrobial resistance surveillance market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in this market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in this market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain

What Defines the Antimicrobial Resistance Surveillance Market?

The antimicrobial resistance (AMR) surveillance market consists of revenues earned by entities by providing services such as diagnostic testing services, surveillance data collection and analysis, antimicrobial stewardship programs, and infection control and prevention services. The market value includes the value of related goods sold by the service provider or included within the service offering. The antimicrobial resistance (AMR) surveillance market also includes sales of diagnostic equipment and tools, antimicrobial agents, laboratory instruments, and software and data analytics platforms. Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

How is Market Value Defined and Measured?

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified). The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.